Jonathan Piazza

Chief Financial Officer

Professional Overview
Jonathan Piazza is an accomplished finance executive with over 15 years of experience in the healthcare and life sciences industries. As the Chief Financial Officer at Orbital Therapeutics, he is responsible for overseeing the company's financial strategy, reporting, and operations, contributing to its growth and success in the rapidly evolving biotechnology sector.

Experience Summary

Current Role
In his current role as Chief Financial Officer at Orbital Therapeutics, Jonathan is instrumental in driving the company's financial performance and supporting its strategic initiatives. He oversees all aspects of financial planning, reporting, and risk management, ensuring the efficient allocation of resources and alignment with the organization's long-term objectives.

Career Progression
Prior to joining Orbital Therapeutics, Jonathan served as the Chief Financial Officer at Silverback Therapeutics, where he played a pivotal role in the company's successful IPO and subsequent growth. Before that, he held senior investment banking positions at Goldman Sachs and Barclays, where he specialized in advising healthcare and life sciences clients on strategic transactions, capital raising, and financial optimization.

Academic Background
Jonathan holds a Bachelor of Science degree in Finance from the Massachusetts Institute of Technology (MIT) and a Master of Business Administration (MBA) from the Harvard Business School. He is recognized for his academic excellence and has been the recipient of several prestigious scholarships and awards throughout his educational journey.

Areas of Expertise

• Financial strategy and planning

• Capital markets and corporate finance

• Mergers, acquisitions, and strategic transactions

• Financial reporting and risk management

• Operational and organizational optimization

Professional Impact
During his tenure at Silverback Therapeutics, Jonathan played a crucial role in guiding the company through a successful IPO, raising over $200 million in capital to fuel its innovative drug development pipeline. His strategic financial guidance and operational expertise have consistently contributed to the growth and profitability of the organizations he has served.

Conclusion
With his extensive experience, academic credentials, and proven track record of success, Jonathan Piazza is a respected and influential finance leader in the healthcare and life sciences industries. As the Chief Financial Officer at Orbital Therapeutics, he is well-positioned to continue driving the company's financial transformation and strategic growth, contributing to its long-term success in the dynamic biotechnology landscape.